Skip to main content

Christopher Lillieberg

Analyst

Carnegie

Equibles does not estimate personal net worth.

About Christopher Lillieberg

Christopher Lillieberg is recorded as Analyst at Carnegie. Christopher Lillieberg has spoken on 4 earnings calls across 4 companies, most recently for BONESUPPORT HOLDING AB on February 24, 2026. Those appearances were for BONESUPPORT HOLDING AB, Humana AB, Bactiguard Holding AB and Attendo AB (publ). The companies whose calls Christopher Lillieberg spoke on are classified in the Healthcare sector.

Christopher Lillieberg on recent calls

“And the better growth in Europe, would you say that's sustainable? Just making sure there is no positive one of larger orders or anything this quarter, explaining the much better growth in Q4 versus what we have seen?”
Analyst — Carnegie, Year-end Report 2025 ·
“And when you say to flatten out in this quarter, do you mean that the number of clients end of 2026 will be on par with what you end 2025 or will it still be done year over year?”
Analyst — Carnegie, Q4 Report 2025 ·
“Or has this changed the agreement and driven by back to God and the fact that you want the opportunity to sign with another partner in Europe simultaneously?”
Analyst — Carnegie, Year-end report 1 January – 31 December 2025 ·

Affiliation history

  • Carnegie

    Analyst

    Transcript header (unverified)

    Current

Company network

BONESUPPORT HOLDING AB

Medical Instruments & Supplies · Healthcare

1 appearance Latest appearance 2026-02-24

Humana AB

Medical Care Facilities · Healthcare

1 appearance Latest appearance 2026-02-06

Bactiguard Holding AB

Medical Devices · Healthcare

1 appearance Latest appearance 2026-02-05

Attendo AB (publ)

Medical Care Facilities · Healthcare

1 appearance Latest appearance 2026-02-05

Recent activity

  • Earnings call

    Year-end Report 2025

    BONESUPPORT HOLDING AB

  • Earnings call

    Q4 Report 2025

    Humana AB

  • Earnings call

    Bokslutskommuniké 2025

    Attendo AB (publ)

  • Earnings call

    Year-end report 1 January – 31 December 2025

    Bactiguard Holding AB